Please login to the form below

Not currently logged in
Email:
Password:

asthma

This page shows the latest asthma news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Six new national standards are launched across UK Six new national standards are launched across UK

    The standards will be launched across ten pilot sites in the UK including Asthma UK Centre for Applied Research, the University of Glasgow, and the Centre for Ageing and Dementia Research.

  • Dermira craters as acne drug fails late-stage test Dermira craters as acne drug fails late-stage test

    s IL-4 and IL-13-targeting drug Dupixent (dupilumab), Pfizer’s new topical treatment Eucrisa (crisaborole) and potentially other drugs such as GlaxoSmithKline’s asthma drug Nucala (mepolizumab), which is

  • FDA hands GSK a reprieve by blocking Novartis generic FDA hands GSK a reprieve by blocking Novartis generic

    Earlier this week GSK said it was factoring in the possibility of generic challengers to the chronic obstructive pulmonary disease (COPD) and asthma blockbuster in the US this year, despite regulatory ... asthma as well as some costly injectable drugs.

  • AZ expects return to growth this year after 2017 decline AZ expects return to growth this year after 2017 decline

    AZ brought five new medicines to market in 2017 - including new cancer medicines Imfinzi (durvalumab) and Calquence (acalabrutinib) as well as Fasenra (benralizumab) for asthma - and added new indications for Lynparza

  • AZ gets EMA green light for severe asthma drug Fasenra AZ gets EMA green light for severe asthma drug Fasenra

    AZ gets EMA green light for severe asthma drug Fasenra. The biologic respiratory treatment will go up against GSK’s Nucala and Teva’s Cinqaero. ... AstraZeneca has picked up an approval in the EU for its interleukin-5 inhibitor Fasenra in severe

More from news
Approximately 58 fully matching, plus 466 partially matching documents found.

Latest Intelligence

  • Six degrees of participation Six degrees of participation

    individual. We can tell a GP in Hull that Joan in Stepney is not happy with her asthma care. ... If we know that Joan and others are unhappy with asthma services in Hull, let’s collaborate to determine what we can do to help.

  • The good, the bad and the ugly The good, the bad and the ugly

    Its revenues grew by a further 9% last year. “A large percentage of this growth was driven by Ellipta, but Nucala - a biologic approved for asthma and COPD - also played its

  • Integrating digital biomarkers into precision medicine Integrating digital biomarkers into precision medicine

    Such monitoring could also allow for early prediction of treatment success, eg in a study to evaluate asthma treatment outcomes.

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Asthma is one of the most significant non-communicable diseases of the 21st century. ... The two professors led The Lancet Clinical Commission, ‘After asthma: redefining airways diseases’in 2015.

  • US health reforms US health reforms

    To cite just one example, patients with financial need get an 85% discount on the popular asthma drug Advair, and that’s by no means an outlier markdown.

More from intelligence
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Raising Awareness: It’s World COPD Day today!

    7).The management of COPD could therefore be improved by limiting the use of ICS to the minority who might actually benefit; in particular COPD patients with asthma– COPD overlap syndrome ... Genetic background, clinical presentation, comorbidities,

  • Does wearable technology really have the potential to enhance modern healthcare?

    Apps available through HealthKit can track users’ health and allow doctors and patients to remotely monitor chronic diseases, such as diabetes and asthma. ... Another app aims to help people with asthma track their medical adherence and lung function.

  • Telehealth Research

    Telehealth services are being used by more and more patients with chronic diseases such as asthma, COPD, diabetes and cardiovascular disease.

  • Take a walk on the wild side!

    type 2 diabetes, asthma, stroke and some cancers.’ That’ s quite a list of benefits for something so simple!

  • A Bitter Pill?

    For lung diseases such as asthma and COPD, where inhalers are the most effective way to deliver medications to the target, this is particularly relevant because success is so dependent on

More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics